Survivin Expression in Intracranial Ependymomas and Its Correlation With Tumor Cell Proliferation and Patient Outcome
|
|
- Myron Abner Barrett
- 5 years ago
- Views:
Transcription
1 Anatomic Pathology / SURVIVIN EXPRESSION IN EPENDYMOMA Survivin Expression in Intracranial Ependymomas and Its Correlation With Tumor Cell Proliferation and Patient Outcome Matthias Preusser, MD, 1 Stefan Wolfsberger, MD, 2 Thomas Czech, MD, 2 Irene Slavc, MD, 3 Herbert Budka, MD, 1 and Johannes A. Hainfellner, MD 1 Key Words: Apoptosis; Ependymoma; Proliferation; Prognosis; Survivin DOI: /PP2G5GAAFKV82DTG Abstract Survivin expression has been described as a prognostic factor in various tumor types and has been shown to correlate with cytologic anaplasia in ependymoma. We immunohistochemically studied survivin expression and its association with Ki-67 and topoisomerase IIα (TIIα) expression and outcome in 63 patients with intracranial ependymoma. Survivin is expressed in a fraction of nuclei of tumor and endothelial cells including mitotic figures. Survivin indices range from 0.6% to 43.2% and correlate with Ki-67 and TIIα indices. On average, 62.86% of Ki-67 expressing tumor cell nuclei coexpress survivin, whereas 92.2% of survivin-expressing nuclei coexpress Ki-67. High survivin, Ki-67, and TIIα indices univariately correlated with an unfavorable outcome. In multivariate analysis, only the Ki-67 index remained an independent prognostic factor. In ependymoma, survivin is expressed in a subset of proliferating cells. High survivin expression is associated with poor patient outcome. However, the Ki-67 index is a more accurate prognostic marker than the survivin or TIIα index. Survivin is a recently identified protein that acts as an inhibitor of apoptosis by preventing caspase-9 activation within a functional apoptosome. In addition, survivin regulates mitosis 1,2 by stabilizing microtubules in metaphase spindle formation and regulation of the spindle assembly checkpoint. 3 High expression of survivin has been associated with an unfavorable prognosis in a large number of malignant neoplasms 4-13 and also has been described as a marker of favorable prognosis in some tumor types In a recent study, Preusser et al 17 showed that survivin is expressed in proliferating tumor cells in glioblastoma. In ependymoma, loss of nuclear survivin expression was reported to associate with cytologic anaplasia. 18 In a recent study, Wolfsberger et al 19 showed that the Ki- 67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma. Considering the role of survivin as regulator of mitosis, its expression might be associated with tumor cell proliferation and patient outcome in ependymoma. To test the prognostic accuracy of survivin in relation to other tumor cell proliferation markers, we revisited the ependymoma series of Wolfsberger et al 19 and systematically analyzed survivin expression and its correlation with tumor cell proliferation markers Ki-67 and topoisomerase IIα (TIIα). Furthermore, we analyzed the impact of survivin expression on patient outcome. Materials and Methods Patients In a previous study, Wolfsberger et al 19 analyzed a cohort of 103 patients who underwent the first operation for intracranial Am J Clin Pathol 2005;124: DOI: /PP2G5GAAFKV82DTG 543
2 Preusser et al / SURVIVIN EXPRESSION IN EPENDYMOMA ependymoma between December 1957 and October Of the 103 cases, 40 were excluded from the present study because material was no longer available (5 cases) or owing to methodological difficulties (35 cases; for more detailed information, see Statistical Analysis in the Results section). Patients with survival times less than 30 days (n = 5) were excluded from survival analyses to exclude deaths due to postoperative complications. The patients underwent the first operation between 1957 and 2000 at the University Hospital of Vienna, Vienna, Austria. For statistical comparisons (see Statistical Analysis ), we subdivided our cohort into 3 time-related groups: (1) operation in 1979 or earlier; (2) operation from 1980 through 1990; and (3) operation in 1991 or later. All tumor specimens were reevaluated histologically by a neuropathologist (J.A.H.) and classified as ependymoma (grade II, 44 cases; grade III, 19 cases) according to the current World Health Organization definition. 20,21 In the patient subgroup younger than 2 years old, 8 tumors were infratentorial and 1 was supratentorial. In patients between 2 and 18 years, 16 tumors were infratentorial and 11 were supratentorial. In patients 18 years or older, 8 tumors were infratentorial and 19 were supratentorial. Of the 63 patients, 37 (59%) underwent gross total resection and 25 patients (40%), subtotal tumor resection. In 1 case (2%), no information on the extent of resection was available. For 16 patients (25%), adjuvant chemotherapy and radiotherapy were given; 25 patients (40%) received only radiotherapy and 1 patient (2%) received only chemotherapy. No adjuvant therapy was given to 20 patients (32%), and for 1 patient (2%), insufficient information about adjuvant therapy was available. Immunohistochemical and Immunofluorescent Staining Specimens were fixed routinely in 4% formalin, embedded in paraffin, and cut at a thickness of 3 µm. Sections were deparaffinized in xylene. For antisurvivin immunostaining, sections were incubated for 1 hour with S2367 TargetRetrieval Solution, ph 9.0 (DAKO, Glostrup, Denmark) in a steamer. For anti Ki-67 and anti-tiiα immunostaining, slides were heated in 0.01 mol/l of citrate buffer (ph 6.0) for 30 minutes in a microwave oven at 600 W. We used the following antibodies for immunostaining: antisurvivin FL-142 (polyclonal rabbit, sc-10811, dilution 1:300, overnight incubation, 4 C; Santa Cruz Biotechnology, Santa Cruz, CA), anti Ki-67 (monoclonal mouse, clone MIB-1, dilution 1:50, 25 minutes, room temperature; DAKO), and anti-tiiα (monoclonal mouse, clone JH2.7, dilution 1:20, 60 minutes, room temperature; Neomarkers, Fremont, CA). Detection of immunostaining was performed using the EnVision kit (DAKO), and diaminobenzidine was used as the chromogen. A tissue sample from a brain metastasis of malignant melanoma was used as a positive control sample for antisurvivin immunostaining. Negative control samples included omission of the primary antisurvivin antibody and nonneoplastic central nervous system tissue samples. For Ki-67 survivin double immunolabeling, we used the EnVision kit and diaminobenzidine as the chromogen for survivin. For Ki-67, we used biotinylated antimouse antibody (DAKO) and streptavidin alkaline phosphatase (DAKO) with fast blue (0.5%, minutes) as the chromogen. For Ki-67 survivin nucleic acid and TIIα survivin nucleic acid triple immunofluorescent staining, the fluorescent-labeled secondary antibody for anti Ki-67 and anti- TIIα was Alexa Fluor 488 goat antimouse IgG (dilution 1:200; Molecular Probes, Eugene, OR). For survivin, we used Alexa Fluor 633 goat antimouse IgG (dilution 1:200; Molecular Probes). Nuclei were labeled using the Sytox Orange Nucleic Acid Stain (S-11368, Molecular Probes) according to the manufacturer s instructions. For Ki- 67 TIIα survivin triple immunofluorescent staining, the secondary antibody for TIIα was Alexa Fluor 546 goat antimouse IgG (dilution 1:200; Molecular Probes). Immunofluorescent labeling was evaluated using a Zeiss LSM 510 confocal laser microscope (Carl Zeiss, Vienna, Austria). We used argon 488-nm and helium/neon 546-nm and 633-nm lasers to elicit fluorescence. Evaluation For the assessment of survivin, Ki-67, and TIIα immunolabeling, 500 tumor cell nuclei were evaluated in each specimen in fields showing the highest density of immunopositive nuclei. The fraction of labeled tumor cell nuclei was expressed as a percentage (survivin, Ki-67, or TIIα index). In 5 cases, double staining for survivin and Ki-67 was performed for evaluation of the fraction of survivin-coexpressing nuclei per 500 Ki-67 expressing nuclei and of the fraction of Ki-67 coexpressing nuclei per 500 survivinexpressing nuclei. Statistical Analysis The Spearman coefficient of correlation, χ 2 test, Wilcoxon signed rank test, and Fisher exact test were used as appropriate. Survival probabilities were computed as outlined by Kaplan and Meier. 22 The log-rank test and Cox proportional hazards model were used for univariate and multivariate analyses of overall survival. Overall survival was defined from the day of initial surgery until death of the patient. Death due to a cause other than ependymoma or survival until the end of the observation period were considered as censoring events in statistical survival analysis. The median was defined as the cutoff value between low and high survivin, Ki-67, and TIIα indices. The survivin, Ki-67, and TIIα indices were entered into Cox regression. For all tests, a 2-tailed P value of.05 or less was considered significant. 544 Am J Clin Pathol 2005;124: DOI: /PP2G5GAAFKV82DTG
3 Anatomic Pathology / ORIGINAL ARTICLE Results Immunohistochemical and Immunofluorescent Staining Antisurvivin immunostaining was performed on a total of 98 cases in which anti Ki-67 and anti-tiiα yielded satisfactory staining results. In 35 of 98 cases, survivin could not be visualized properly (no immunoreactive structures including unstained mitotic figures), apparently owing to material or methodological reasons. (These were mainly older blocks; for more details, see the following Statistical Analysis section). These cases were excluded from further analyses. In 63 of 98 cases used for further analysis, survivin expression was prominent in a fraction of nuclei of tumor cells Image 1A and endothelial cells Image 1B throughout the specimen. Antisurvivin labeled all mitotic figures Image 1C, Image 1D, Image 1E, and Image 1F. Faint cytoplasmic expression was seen in a few tumor cells. There was no antisurvivin staining of surrounding nonneoplastic central nervous system tissue. Quantitative results for survivin, Ki-67, and TIIα expression are summarized in Table 1. Triple immunofluorescent staining and confocal microscopy showed that Ki-67, TIIα, and survivin were coexpressed in a fraction of tumor cell nuclei (Image 1C-1F) Image 1G, Image 1H, Image 1I, and Image 1J. Double immunolabeling analysis of 5 cases showed that a mean of 62.9% (range, 43.8%-76.6%) of Ki-67 expressing tumor cell nuclei coexpressed survivin. In contrast, a mean of 92.2% (range, 86.6%-96.8%) of survivin-expressing nuclei coexpressed Ki-67. Statistical comparison of Ki-67 and survivin index levels including all cases showed that the Ki-67 index was consistently higher than the survivin index (P <.0001; Wilcoxon signed rank test). Statistical Analysis The median patient age at surgery was 11.3 years (range, years). The mean survival time was 7.7 years for patients with grade II tumors and 3.2 years for patients with grade III tumors. Of 63 patients, 31 (49%) died of disease, and 32 patients (51%) were lost to follow-up or died of causes other than ependymoma. There was a significantly higher number of cases that had to be excluded for material or methodological reasons (see also earlier text) during the period before 1979 than in the later periods (P =.001; χ 2 test). So survivin immunodetectability seems to be affected by tissue processing factors in earlier times or duration of tissue sample storage. High survivin (P =.003; Fisher exact test), high Ki- 67 (P =.018; Fisher exact test), and high TIIα (P =.028; Fisher exact test) indices are associated significantly with tumor grade III. The survivin index showed significant correlation with the Ki-67 and TIIα indices Figure 1. Statistical comparison of the Ki-67 and survivin index levels showed that the Ki-67 index was consistently higher than the survivin index (P <.0001; Wilcoxon signed rank test). The survivin, Ki-67, and TIIα indices correlated significantly with overall survival in univariate analysis (Table 1, Figure 1). In multivariate analysis, only the Ki-67 index remained an independent prognostic factor (Table 1). There was no statistically significant difference in survival times between patients with supratentorial vs infratentorial tumors (P =.8357; log-rank test), patients in different age groups ( 2 years, 2-18 years, >18 years; P =.3135; log-rank test), or patients treated during different periods (P =.3534; logrank test). Discussion Immunohistochemical analysis of survivin expression in ependymoma was performed in 2 previous studies on small series of cases. 18,23 In 1 study, survivin expression was described in the cytoplasm but not in the nuclei of tumor cells. 23 In contrast, we observed that immunostaining signals are particularly prominent in tumor cell nuclei and barely visible in the cytoplasm. In vitro studies have shown the presence of survivin in the cytoplasm, cell nuclei, and mitotic apparatus. 2 Different antisurvivin antibodies bind more strongly to cytoplasmic survivin and others to nuclear survivin. We used antibody sc (Santa Cruz Biotechnology), which has been proven to specifically detect survivin in brain tissue by immunohistochemical analysis and Western blotting. 18 It has been described to bind predominantly to nuclear survivin. 18 So one explanation for the discrepancies of our results with previous findings in ependymoma might be the use of different antibodies. Another study on pediatric ependymomas and choroid plexus tumors reported that nuclear expression of survivin correlated with morphologic tumor grade. 18 Cases with high tumor grade had a lower fraction of survivin-expressing tumor cells than did low-grade tumors. In contrast, we found in our larger series a significant correlation of a high survivin index with high tumor grade. In our hands, confocal laser scanning microscopy showed colocalization of Ki-67, TIIα, and survivin in tumor cell nuclei including mitotic figures. These findings confirm expression of survivin in proliferating cells. Tumor cell proliferation commonly is assessed by anti Ki-67 immunostaining To assess survivin as a potential alternative tumor cell proliferation marker, we compared the relation of Ki-67 and survivin expression in tumor cell nuclei. We found by double immunolabeling studies and statistical analysis that anti Ki- 67 stains a significantly larger fraction of tumor cells than does antisurvivin. These findings are in line with previous in vitro studies showing that Ki-67 (expression in G 1, S, G 2, and Am J Clin Pathol 2005;124: DOI: /PP2G5GAAFKV82DTG 545
4 Preusser et al / SURVIVIN EXPRESSION IN EPENDYMOMA A B C D E F G H I J Image 1 Antisurvivin labels nuclei of tumor cells (A, antisurvivin, original magnification 600) and endothelial cells (B, antisurvivin, original magnification 200). C, D, E, and F, Topoisomerase IIα and survivin are coexpressed in a mitotic figure (nucleic acids, blue signal; topoisomerase IIα, red signal; survivin, green signal; original magnification 1,000). F is a merged image of C-E. G, H, I, and J, Ki-67, topoisomerase IIα, and survivin are coexpressed in a tumor cell nucleus (Ki-67, blue signal; topoisomerase IIα, red signal; survivin, green signal; original magnification 1,000). J is a merged image of G-I. 546 Am J Clin Pathol 2005;124: DOI: /PP2G5GAAFKV82DTG
5 Anatomic Pathology / ORIGINAL ARTICLE M phases) 31,32 is expressed in a larger segment of the cell cycle than survivin (G 2 and M phases) 2 or TIIα (S, G 2, and M phases). 33 We conclude that anti Ki-67 identifies proliferating tumor cells more sensitively than does antisurvivin. Univariate survival analysis showed significant correlation of Ki-67, TIIα, and survivin indices with patient outcome. With multivariate analysis including all 3 factors, only the Ki- 67 index remained an independent prognostic parameter. So Table 1 Quantitative Results of Survivin, Ki-67, and Topoisomerase IIα Expression and of Univariate and Multivariate Survival Analyses Range (%) P Index Overall Grade II Grade III Median Cutoff (%) No. of Cases Log-Rank Test Cox Regression Ki *.019 * > Topoisomerase IIα *.570 > Survivin *.886 > * Statistically significant. A Cumulative Overall Survival C Low survivin index (n = 30) High survivin index (n = 28) Survival Time (y) B Ki-67 Index Survivin Index Figure 1 A, Kaplan-Meier curve showing significantly better outcome for patients with a low survivin index (P =.0032). B and C, Scatter plots showing significant correlation of the survivin index with the Ki-67 index (B, r = 0.586; P <.0001) and the topoisomerase IIα (TIIα) index (C, r = 0.733; P <.0001). 40 TIIα Index Survivin Index Am J Clin Pathol 2005;124: DOI: /PP2G5GAAFKV82DTG 547
6 Preusser et al / SURVIVIN EXPRESSION IN EPENDYMOMA the Ki-67 index more accurately predicts patient outcome. This finding might be explained by more sensitive identification of proliferating cells by anti Ki-67. Thus, anti Ki-67 should be the first choice as a tumor cell proliferation marker in the clinical setting. The prognostic impact of survivin expression has been analyzed in various tumor types. In most tumor types, high survivin expression correlated with an unfavorable patient outcome, 4-13 whereas in a few tumor types (eg, gastric cancer, breast cancer) it correlated with a favorable outcome To our knowledge, only 1 previous study on mantle cell lymphoma compared the prognostic influence of survivin and Ki In that study, survivin and Ki-67 correlated with patient outcome in univariate analysis. With multivariate analysis, only the Ki-67 index remained an independent predictor of survival. By comparing the impact of survivin and Ki-67 in ependymoma, we obtained analogous results. Thus, the Ki-67 index seems to predict patient outcome more accurately than does the survivin index in different cancer types. Survivin is expressed in ependymoma predominantly in a subset of proliferating tumor cell nuclei. High survivin expression is associated with an unfavorable patient outcome in intracranial ependymoma. However, the Ki-67 index predicts the outcome for patients with ependymoma more accurately than does the survivin index. From the 1 Institute of Neurology, 2 Department of Neurosurgery, and 3 Department of Pediatrics, Medical University of Vienna, Vienna, Austria. The study was performed within the Austrian Neuro- Oncology Network ( Vienna. Address reprint requests to Dr Hainfellner: Institute of Neurology, Medical University of Vienna, AKH 4J, Waehringer Guertel 18-20, POB 48, A-1097 Vienna, Austria. Acknowledgments: We thank Judith Ludwig, Gerda Ricken, and Helga Flicker, Institute of Neurology, Medical University of Vienna, and Evelin Simek, Medical Media Services, Medical University of Vienna for excellent technical assistance. References 1. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3: Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396: Altieri DC. Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. J Cell Biochem. 2004;92: Adida C, Haioun C, Gaulard P, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 2000;96: Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer. 2003;88: Kajiwara Y, Yamasaki F, Hama S, et al. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer. 2003;97: Kami K, Doi R, Koizumi M, et al. Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery. 2004;136: Kappler M, Kotzsch M, Bartel F, et al. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin Cancer Res. 2003;9: Martinez A, Bellosillo B, Bosch F, et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am J Pathol. 2004;164: Sarela AI, Macadam RC, Farmery SM, et al. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 2000;46: Sarela AI, Scott N, Ramsdale J, et al. Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol. 2001;8: Schlette EJ, Medeiros LJ, Goy A, et al. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol. 2004;22: Span PN, Sweep FC, Wiegerinck ET, et al. Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin Chem. 2004;50: Kennedy SM, O Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer. Br J Cancer. 2003;88: Okada E, Murai Y, Matsui K, et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett. 2001;163: Trieb K, Lehner R, Stulnig T, et al. Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol. 2003;29: Preusser M, Gelpi E, Matej R, et al. No prognostic impact of survivin expression in glioblastoma. Acta Neuropathol (Berl). 2005;109: Altura RA, Olshefski RS, Jiang Y, et al. Nuclear expression of survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br J Cancer. 2003;89: Wolfsberger S, Fischer I, Hoftberger R, et al. Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma. Am J Surg Pathol. 2004;28: Kleihues P, Cavenee W, eds. Pathology and Genetics of Tumours of the Nervous System. Lyon, France: IARC Press; World Health Organization Classification of Tumours. 21. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61: Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1985;53: Sasaki T, Lopes MB, Hankins GR, et al. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol (Berl). 2002;104: Bredel M, Piribauer M, Marosi C, et al. High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients. Eur J Cancer. 2002;38: Am J Clin Pathol 2005;124: DOI: /PP2G5GAAFKV82DTG
7 Anatomic Pathology / ORIGINAL ARTICLE 25. Chiesa-Vottero AG, Rybicki LA, Prayson RA. Comparison of proliferation indices in glioblastoma multiforme by whole tissue section vs tissue microarray. Am J Clin Pathol. 2003;120: Dictor M, Ehinger M, Mertens F, et al. Abnormal cell cycle regulation in malignancy. Am J Clin Pathol. 1999;112(1 suppl 1):S40-S Ho DM, Hsu CY, Ting LT, et al. MIB-1 and DNA topoisomerase II alpha could be helpful for predicting longterm survival of patients with glioblastoma. Am J Clin Pathol. 2003;119: Hsu DW, Louis DN, Efird JT, et al. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas. J Neuropathol Exp Neurol. 1997;56: Prayson RA. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases. Am J Clin Pathol. 1998;110: Rickert CH, Paulus W. Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence. Acta Neuropathol (Berl). 2005;109: Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133: Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182: Agostinho M, Rino J, Braga J, et al. Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis. Mol Biol Cell. 2004;15: Am J Clin Pathol 2005;124: DOI: /PP2G5GAAFKV82DTG 549
Correlation between survivin expression and prognosis in non-small cell lung cancer
Respiratory Medicine (2006) 100, 2220 2226 Correlation between survivin expression and prognosis in non-small cell lung cancer Sükran Atikcan a, Ebru Ünsal a,, Funda Demirag b, Deniz Köksal a, Aydın Yilmaz
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationComparison of Proliferation Indices in Glioblastoma Multiforme by Whole Tissue Section vs Tissue Microarray
Anatomic Pathology / WHOLE TISSUE SECTION VS MICROARRAY Comparison of Proliferation Indices in Glioblastoma Multiforme by Whole Tissue Section vs Tissue Microarray Andres G. Chiesa-Vottero, MD, 1 Lisa
More informationJ of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 19/May 12, 2014 Page 5307
PROGNOSTIC SIGNIFICANCE OF PROLIFERATIVE ACTIVITY (KI67 EXPRESSION) IN OSTEOSARCOMA IN CHILDREN Moumita Paul 1, Arnab Karmakar 2, Uttara Chatterjee 3, Uttam Kumar Saha 4, Koushik Saha 5, Nanda Dulal Chatterjee
More informationPROCARBAZINE, lomustine, and vincristine (PCV) is
RAPID PUBLICATION Procarbazine, Lomustine, and Vincristine () Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine
More informationAnaplastic Pilocytic Astrocytoma: The fusion of good and bad
Anaplastic Pilocytic Astrocytoma: The fusion of good and bad Alexandrina Nikova 1, Charalampos-Chrysovalantis Chytoudis-Peroudis 2, Penelope Korkolopoulou 3 and Dimitrios Kanakis 4 Abstract 5 Pilocytic
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationMitosin and phh3 predict poorer survival in astrocytomas WHO grades II and III
JCP Online First, published on July 17, 2015 as 10.1136/jclinpath-2015-202983 Original article Mitosin and phh3 predict poorer survival in astrocytomas WHO grades II and III R K Varughese, 1 T Lind-Landström,
More informationCharacterization of morphologically benign biologically aggressive meningiomas
Characterization of morphologically benign biologically aggressive meningiomas Original Article Shalinee Rao, N. Sadiya, Saraswathi Doraiswami, D. Prathiba Department of Pathology, Sri Ramachandra Medical
More informationSupplementary Fig. 1: ATM is phosphorylated in HER2 breast cancer cell lines. (A) ATM is phosphorylated in SKBR3 cells depending on ATM and HER2
Supplementary Fig. 1: ATM is phosphorylated in HER2 breast cancer cell lines. (A) ATM is phosphorylated in SKBR3 cells depending on ATM and HER2 activity. Upper panel: Representative histograms for FACS
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationCorrelation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
1568 Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients LIYING GUO 1, YU ZHANG 2, WEI ZHANG 3 and DILIMINA YILAMU 1 1 Department of
More informationCNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 12: CNS tumours 2/3
CNS pathology Third year medical students Dr Heyam Awad 2018 Lecture 12: CNS tumours 2/3 Pilocytic astrocytoma Relatively benign ( WHO grade 1) Occurs in children and young adults Mostly: in the cerebellum
More informationCCSS Concept Proposal Working Group: Biostatistics and Epidemiology
Draft date: June 26, 2010 CCSS Concept Proposal Working Group: Biostatistics and Epidemiology Title: Conditional Survival in Pediatric Malignancies: A Comparison of CCSS and SEER Data Proposed Investigators:
More information(a) Significant biological processes (upper panel) and disease biomarkers (lower panel)
Supplementary Figure 1. Functional enrichment analyses of secretomic proteins. (a) Significant biological processes (upper panel) and disease biomarkers (lower panel) 2 involved by hrab37-mediated secretory
More informationBasaloid Carcinoma of the Lung: A Really Dismal Histologic Variant?
Carcinoma of the Lung: A Really Dismal Histologic Variant? Dae Joon Kim, MD, Kil Dong Kim, MD, Dong Hwan Shin, MD, Jae Y Ro, MD, and Kyung Young Chung, MD Departments of Thoracic and Cardiovascular Surgery,
More informationHistological Typing Of Cancer And Precancer Of The Oral Mucosa
Histological Typing Of Cancer And Precancer Of The Oral Mucosa 1 / 7 2 / 7 3 / 7 Histological Typing Of Cancer And Within the last decade, histologic grading has become widely accepted as a powerful indicator
More informationHigh expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.
Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei
More informationBreast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience
Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Curzon M, Curzon C, Heidel RE, Desai P, McLoughlin J, Panella T, Bell
More informationHypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients
Journal of BUON 17: 663-668, 2012 2012 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor
More informationRevisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis
Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationTable of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS
Staining Atlas Table of Contents 1. Overview 1.1 Introduction 1.2 Role of p16 INK4a 1.3 Role of Ki-67 1.4 Molecular Pathogenesis 1.5 p16 INK4a Expression in Cervical Dysplasia 1.6 The Concept of CINtec
More informationSupplementary Figure 1. HOPX is hypermethylated in NPC. (a) Methylation levels of HOPX in Normal (n = 24) and NPC (n = 24) tissues from the
Supplementary Figure 1. HOPX is hypermethylated in NPC. (a) Methylation levels of HOPX in Normal (n = 24) and NPC (n = 24) tissues from the genome-wide methylation microarray data. Mean ± s.d.; Student
More informationImmunohistochemical Staining for Claudin-1 Can Help Distinguish Meningiomas From Histologic Mimics
Anatomic Pathology / CLAUDIN-1 IN MENINGIOMAS Immunohistochemical Staining for Claudin-1 Can Help Distinguish Meningiomas From Histologic Mimics Hejin P. Hahn, MD, PhD, Elizabeth A. Bundock, MD, PhD, and
More informationSurvivin and gliomas: A literature review
ONCOLOGY LETTERS 12: 1679-1686, 2016 Survivin and gliomas: A literature review ROSILIN KOTAKKATHU VARUGHESE 1 and SVERRE HELGE TORP 1,2 1 Department of Laboratory Medicine, Children's and Women's Health,
More informationmonotonous, stippled, round, smoothcontoured nuclei and scanty acidophilic or
monotonous, stippled, round, smoothcontoured nuclei and scanty acidophilic or vacuolated cytoplasm. The cells are surrounded by a loose fibrillary stroma that is traversed by delicate capillaries. Ill
More informationCell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-
Supplemental material and methods Reagents. Hydralazine was purchased from Sigma-Aldrich. Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC- 133, human thyroid medullary
More informationSupplementary Online Content
Supplementary Online Content Bell EH, Pugh SL, McElroy JP, et al. Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era: a correlative analysis based on NRG Oncology
More informationAndrogen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?
Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? New Frontiers in Urologic Oncology Juan Chipollini, MD Clinical Fellow Department of Genitourinary Oncology Moffitt Cancer
More informationMeningiomas represent between 13 and
RESEARCH EXPERIMENTAL (LABORATORY) Mitotic Count, Brain Invasion, and Location Are Independent Predictors of Recurrence-Free Survival in Primary Atypical and Malignant Meningiomas: A Study of 86 Patients
More informationCD15 and CEA expression in thymic epithelial neoplasms
Turkish Journal of Cancer Volume 8, No., 8 CD and CEA expression in thymic epithelial neoplasms AYTEKİN AKYOL, AYŞEGÜL ÜNER Hacettepe University, Department of Pathology, Ankara-Turkey ABSTRACT The aim
More informationClinical relevance of Fas expression in oesophageal squamous cell carcinoma.
Clinical relevance of Fas expression in oesophageal squamous cell carcinoma. Author Chan, K, Lee, P, Lam, Alfred, Law, S, Wong, J, Srivastava, G Published 2006 Journal Title Journal of Clinical Pathology
More informationp53 expression in invasive pancreatic adenocarcinoma and precursor lesions
Malaysian J Pathol 2011; 33(2) : 89 94 ORIGINAL ARTICLE p53 expression in invasive pancreatic adenocarcinoma and precursor lesions NORFADZILAH MY MBBCH,* Jayalakshmi PAILOOR MPath, FRCPath,* RETNESWARI
More informationAMERICAN ASSOCIATION OF NEUROPATHOLOGISTS COMPANION SOCIETY MEETING at the 106 th ANNUAL MEETING OF THE USCAP San Antonio, March 4, 2017
AMERICAN ASSOCIATION OF NEUROPATHOLOGISTS COMPANION SOCIETY MEETING at the 106 th ANNUAL MEETING OF THE USCAP San Antonio, March 4, 2017 SYLLABUS Papillary Tumor of the Pineal Region and the Differential
More informationOriginal Article Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma
Int J Clin Exp Med 2015;8(5):7837-7842 www.ijcem.com /ISSN:1940-5901/IJCEM0003844 Original Article Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma Tingting Zhang, Dan
More information3/22/2017. Disclosure of Relevant Financial Relationships. Ki-67 in Pancreatic Neuroendocrine Neoplasms According to WHO 2017.
Disclosure of Relevant Financial Relationships Ki-67 in Pancreatic Neuroendocrine Neoplasms According to WHO 2017. USCAP requires that all planners (Education Committee) in a position to influence or control
More informationBcl-2 and p53 protein expression in all grades of astrocytomas
Southern Adventist Univeristy KnowledgeExchange@Southern Senior Research Projects Southern Scholars 11-1994 Bcl-2 and p53 protein expression in all grades of astrocytomas Robyn L. Castleberg Follow this
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationCharacterizing invading glioma cells based on IDH1-R132H and Ki-67 immunofluorescence
DOI 10.1007/s10014-013-0172-y ORIGINAL ARTICLE Characterizing invading glioma cells based on IDH1-R132H and Ki-67 immunofluorescence Hemragul Sabit Mitsutoshi Nakada Takuya Furuta Takuya Watanabe Yutaka
More informationRapid recurrence of a malignant meningioma: case report
Romanian Neurosurgery Volume XXXI Number 2 2017 April-June Article Rapid recurrence of a malignant meningioma: case report Oguz Baran, Sima Sayyahmeli, Taner Tanriverdi, Pamir Erdincler TURKEY DOI: 10.1515/romneu-2017-0027
More informationResearch Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
SAGE-Hindawi Access to Research International Breast Cancer Volume 20, Article ID 47957, 4 pages doi:0.406/20/47957 Research Article Stromal Expression of CD0 in Invasive Breast Carcinoma and Its Correlation
More informationSUPPLEMENTARY INFORMATION
VOLUME: 1 ARTICLE NUMBER: 0027 In the format provided by the authors and unedited. Rapid intraoperative histology of unprocessed surgical specimens via fibre-laser-based stimulated Raman scattering microscopy
More informationCorporate Medical Policy
Corporate Medical Policy Analysis of MGMT Promoter Methylation in Malignant Gliomas File Name: Origination: Last CAP Review: Next CAP Review: Last Review: analysis_of_mgmt_promoter_methylation_in_malignant_gliomas
More informationFang et al. NMuMG. PyVmT unstained Anti-CCR2-PE MDA-MB MCF MCF10A
A NMuMG PyVmT 16.5+.5 47.+7.2 Fang et al. unstained Anti-CCR2-PE 4T1 Control 37.6+6.3 56.1+.65 MCF1A 16.1+3. MCF-7 3.1+5.4 MDA-M-231 42.1+5.5 unstained Secondary antibody only Anti-CCR2 SUPPLEMENTAL FIGURE
More informationCNS TUMORS. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
CNS TUMORS D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) CNS TUMORS The annual incidence of intracranial tumors of the CNS ISmore than intraspinal tumors May be Primary or Secondary
More informationSupplementary Information. Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent
Supplementary Information Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent Authors: Susanne Kossatz a, Christian Brand a, Stanley Gutiontov b, Jonathan T.C. Liu c, Nancy
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bredel M, Scholtens DM, Yadav AK, et al. NFKBIA deletion in
More informationTechnique and feasibility of a dual staining method for estrogen receptors and AgNORs
151 Technical note Technique and feasibility of a dual staining method for estrogen receptors and AgNORs Lukas Günther a, and Peter Hufnagl b a Department of Surgery, University of Heidelberg, Heidelberg,
More informationHigher expression of deoxyuridine triphosphatase (dutpase) may predict the metastasis potential of colorectal cancer
1 Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan; 2 Department of Surgery, Kurume University School of Medicine, Kurume, Japan; 3 Biostatistics Center, Kurume University,
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationDiplomate of the American Board of Pathology in Anatomic and Clinical Pathology
A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory
More informationPrognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer
Prognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer Hee Jung Kwon, Nuri Jang, Min Hui Park, Young Kyung Bae Department of Pathology, Yeungnam
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationPrognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma
ORIGINAL ARTICLE Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma Rita G. Ladstein 1, Ingeborg M. Bachmann 1,2, Oddbjørn Straume 1 and Lars A. Akslen 1,3 Mitotic
More informationSolitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation
246) Prague Medical Report / Vol. 113 (2012) No. 3, p. 246 250 Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation Sfoungaristos S., Papatheodorou M., Kavouras
More informationCerebral Parenchymal Lesions: I. Metastatic Neoplasms
Chapter 4 Cerebral Parenchymal Lesions: I. Metastatic Neoplasms After one has reasonably ruled out the possibility of a nonneoplastic diagnosis (see Chap. 3), one is left with considering a diagnosis of
More informationDako IT S ABOUT TIME. Interpretation Guide. Agilent Pathology Solutions. ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis)
INTERPRETATION Dako Agilent Pathology Solutions IQFISH Interpretation Guide ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis) IT S ABOUT TIME For In Vitro Diagnostic Use ALK, ROS1,
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationLarge Colorectal Adenomas An Approach to Pathologic Evaluation
Anatomic Pathology / LARGE COLORECTAL ADENOMAS AND PATHOLOGIC EVALUATION Large Colorectal Adenomas An Approach to Pathologic Evaluation Elizabeth D. Euscher, MD, 1 Theodore H. Niemann, MD, 1 Joel G. Lucas,
More informationDetection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing
DOI.7/s4--3-7 ORIGINAL ARTICLE Detection of IDH mutation in human gliomas: comparison of immunohistochemistry and sequencing Shingo Takano Wei Tian Masahide Matsuda Tetsuya Yamamoto Eiichi Ishikawa Mika
More informationGeisinger Clinic Annual Progress Report: 2011 Nonformula Grant
Geisinger Clinic Annual Progress Report: 2011 Nonformula Grant Reporting Period July 1, 2012 June 30, 2013 Nonformula Grant Overview The Geisinger Clinic received $1,000,000 in nonformula funds for the
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationIMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA
& IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA Suada Kuskunović*, Svjetlana Radović, Mirsad Dorić, Ajna Hukić, Mirsad Babić, Ivana Tomić,
More informationAfter primary tumor treatment, 30% of patients with malignant
ESTS METASTASECTOMY SUPPLEMENT Alberto Oliaro, MD, Pier L. Filosso, MD, Maria C. Bruna, MD, Claudio Mossetti, MD, and Enrico Ruffini, MD Abstract: After primary tumor treatment, 30% of patients with malignant
More informationSuperior Fluorescent Labeling Dyes Spanning the Full Visible Spectrum...1. Trademarks: HiLyte Fluor (AnaSpec, Inc.)
Table of Contents Fluor TM Labeling Dyes Superior Fluorescent Labeling Dyes Spanning the Full Visible Spectrum....1 Fluor TM 405 Dye, an Excellent Alternative to Alexa Fluor 405 & DyLight 405....2 Fluor
More informationThe New WHO Classification and the Role of Integrated Molecular Profiling in the Diagnosis of Malignant Gliomas
The New WHO Classification and the Role of Integrated Molecular Profiling in the Diagnosis of Malignant Gliomas Stefan Prokop, MD Neuropathology Fellow Hospital of the University of Pennsylvania Background
More informationCorrelation of Vascular Endothelial Growth Factor Expression and Neovascularization with Colorectal Carcinoma: A Pilot Study
Research Article imedpub Journals http://www.imedpub.com Journal of Adenocarcinoma Vol. 1 No. 1:5 DOI: 10.21767/2572-309X.10005 Correlation of Vascular Endothelial Growth Factor Expression and Neovascularization
More informationRNA extraction, RT-PCR and real-time PCR. Total RNA were extracted using
Supplementary Information Materials and Methods RNA extraction, RT-PCR and real-time PCR. Total RNA were extracted using Trizol reagent (Invitrogen,Carlsbad, CA) according to the manufacturer's instructions.
More informationRelationship of P53 Protein With Histopathology Degree of Intracranial Astrocytoma at Haji Adam Malik Hospital Medan
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.10 No.15, pp 300-304, 2017 Relationship of P53 Protein With Histopathology Degree of Intracranial
More informationAmerican Journal of. Medical Case Reports. CAM5.2 Expression in Metastatic Tumours of CNS: A Diagnostic Tool
American Journal of American Journals of Medical Case Reports http://ivyunion.org/index.php/ajmcr/index Medical Case Reports Mathur SK et al. American Journal of Medical Case Reports 2014, 2:1-8 Vol 2,
More information21/03/2017. Disclosure. Practice Changing Articles in Neuro Oncology for 2016/17. Gliomas. Objectives. Gliomas. No conflicts to declare
Practice Changing Articles in Neuro Oncology for 2016/17 Disclosure No conflicts to declare Frances Cusano, BScPharm, ACPR April 21, 2017 Objectives Gliomas To describe the patient selection, methodology
More informationImmunohistochemical Evaluation of Necrotic Malignant Melanomas
Anatomic Pathology / EVALUATION OF NECROTIC MALIGNANT MELANOMAS Immunohistochemical Evaluation of Necrotic Malignant Melanomas Daisuke Nonaka, MD, Jordan Laser, MD, Rachel Tucker, HTL(ASCP), and Jonathan
More informationModeling origin and natural evolution of low-grade gliomas
Modeling origin and natural evolution of low-grade gliomas Mathilde Badoual Paris Diderot University, IMNC lab 2nd HTE workshop: Mathematical & Computer Modeling to study tumors heterogeneity in its ecosystem,
More informationCACA. Original Article. Wei 鄄 Ying Yue 1,2*, Ke Sai 1,2*, Qiu 鄄 Liang Wu 1,3, Yun 鄄 Fei Xia 1,4, Su 鄄 Huan Yu 5 and Zhong 鄄 Ping Chen 1,2
Chinese Journal of Cancer Original Article Wei 鄄 Ying Yue,*, Ke Sai,*, Qiu 鄄 Liang Wu,3, Yun 鄄 ei Xia,4, Su 鄄 Huan Yu and Zhong 鄄 Ping Chen, Abstract Monitoring the long 鄄 term radiotherapy 鄄 associated
More informationHER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer
P A T H O L O G Y HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer FROM CERTAINTY COMES TRUST For in vitro diagnostic use HER2 CISH pharmdx Kit HER2 CISH pharmdx Kit is intended for dual-color
More informationExpression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues
[Chinese Journal of Cancer 27:12, 568-573; December Expression 2008]; 2008 and significance Sun Yat-sen of University Bmi-1 and Cancer Ki67 in Center colorectal carcinoma tissues Clinical Research Paper
More informationHigh Expression of Forkhead Box Protein C2 is Related to Poor Prognosis in Human Gliomas
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.24.10621 RESEARCH ARTICLE High Expression of Forkhead Box Protein C2 is Related to Poor Prognosis in Human Gliomas Yao-Wu Wang 1, Chun-Li Yin 2, Hong-Yi Zhang
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationDepartment of Urology, Anhui Provincial Hospital, Hefei, China
Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma Y.W. Sun 1,2, Q. Xuan 2 *, Q.A. Shu 2, S.S. Wu
More informationPulmonary resection remains the most effective. Survival in Synchronous vs Single Lung Cancer. Upstaging Better Reflects Prognosis
Survival in Synchronous vs Single Lung Cancer Upstaging Better Reflects Prognosis Marcel Th. M. van Rens, MD; Pieter Zanen, MD, PhD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD;
More informationTitle page. Title: MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in
Title page Title: MicroRNA- Controls Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma Authors Manabu Mikamori, Daisaku Yamada, Hidetoshi Eguchi, Shinichiro Hasegawa, Tomoya
More informationProsigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY Methodology The test is based on the reported 50-gene classifier algorithm originally named PAM50 and is performed on the ncounter Dx Analysis System
More informationProsigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY GENE EXPRESSION PROFILING WITH PROSIGNA What is Prosigna? Prosigna Breast Cancer Prognostic Gene Signature Assay is an FDA-approved assay which provides
More informationBiological predictors of survival in stage II colorectal cancer
MOLECULAR AND CLINICAL ONCOLOGY 1: 643-648, 2013 Biological predictors of survival in stage II colorectal cancer YOSHITAKE UEDA 1, KAZUHIRO YASUDA 1, MASAFUMI INOMATA 1, NORIO SHIRAISHI 1, SHIGEO YOKOYAMA
More informationMarcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD; and Jules M. M. van den Bosch, MD, PhD, FCCP
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA* Marcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans
More informationImpact of Prognostic Factors
Melanoma Prognostic Factors: where we started, where are we going? Impact of Prognostic Factors Staging Management Surgical intervention Adjuvant treatment Suraj Venna, MD Assistant Clinical Professor,
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationEvaluation of cyclin-dependent kinase inhibitor p27 and Bcl-2 protein in nonsmall cell lung cancer
166 Turkish Journal of Cancer Volume 35, No.4, 2005 Evaluation of cyclin-dependent kinase inhibitor p27 and cl-2 protein in nonsmall cell lung cancer LEVENT DERTS Z 1, GÜLY ÖZ L M 2, LKNUR KÜKNER 2, REM
More informationSupplementary Figure 1. A. Bar graph representing the expression levels of the 19 indicated genes in the microarrays analyses comparing human lung
Supplementary Figure 1. A. Bar graph representing the expression levels of the 19 indicated genes in the microarrays analyses comparing human lung immortalized broncho-epithelial cells (AALE cells) expressing
More informationPredicting Prognosis in Lung Cancer: Use of Proliferation Marker, Ki67 Monoclonal Antibody
Predicting Prognosis in Lung Cancer: Use of Proliferation Marker, Ki67 Monoclonal Antibody Pages with reference to book, From 66 To 69 Irshad Nabi Soomro ( Department of Pathology, The Aga Klaan University
More informationClinical analysis of 29 cases of nasal mucosal malignant melanoma
1166 Clinical analysis of 29 cases of nasal mucosal malignant melanoma HUANXIN YU and GANG LIU Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China
More informationSignificance of intracellular localization of survivin in cervical squamous cell lesions: Correlation with disease progression
ONCOLOGY LETTERS 7: 1589-1593, 2014 Significance of intracellular localization of survivin in cervical squamous cell lesions: Correlation with disease progression SOO AH KIM 1 and RAN HONG 2 Departments
More informationDisclosure of Relevant Financial Relationships
Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationANTICANCER RESEARCH 28: (2008)
Comparative Analysis of Four Histopathological Classification Systems to Discriminate Benign and Malignant Behaviour in Gastrointestinal Stromal Tumors D. VALLBÖHMER 1, H.E. MARCUS 1, S.E. BALDUS 2, J.
More informationSurgery remains the mainstay treatment for localized
Surgical Results in T2N0M0 Nonsmall Cell Lung Cancer Patients With Large Tumors 5 cm or Greater in Diameter: What Regulates Outcome? Yasuhiko Ohta, MD, Ryuichi Waseda, MD, Hiroshi Minato, MD, Naoki Endo,
More informationSUPPLEMENTARY INFORMATION
DOI: 10.1038/ncb2607 Figure S1 Elf5 loss promotes EMT in mammary epithelium while Elf5 overexpression inhibits TGFβ induced EMT. (a, c) Different confocal slices through the Z stack image. (b, d) 3D rendering
More informationMultiplex immunofluorescence for investigating the prognostic value of immune cells Chidozie Anyaegbu, PhD
Multiplex immunofluorescence for investigating the prognostic value of immune cells Chidozie Anyaegbu, PhD Catholic Health Australia Symposium Mater Hospital, Brisbane 1 st June 2018 Why colorectal cancer?
More informationImproved Survival after Gross Total Resection of Malignant Gliomas in Pediatric Patients from the HIT-GBM Studies
Improved Survival after Gross Total Resection of Malignant Gliomas in Pediatric Patients from the HIT-GBM Studies CHRISTOF M. KRAMM 1, SABINE WAGNER 2, STEFAN VAN GOOL 3, HANSJÖRG SCHMID 4, RONALD STRÄTER
More information